Fosamax Users Must Disclose Using Generic in MDL

Judge Rules Patients Must Disclose Use of Generic Fosamax in MDL A New York federal judge ruled on Wednesday, December 18th, 2013, that plaintiffs in a multidistrict litigation (MDL) against Teva Pharmaceuticals must disclose whether or not they had used a generic form of Fosamax for bone building, in order to back up claims that the generic … [Read more...]

BestLawyers.comAVBetter Business Bureau